Solid Tumors and Advanced Endometrial Cancer
1 clinical trials · Condition
◉ Watch Solid Tumors and Advanced Endometrial Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer (NCT01379534) | Novartis Pharmaceuticals | 2011-11-01 |
Track Solid Tumors and Advanced Endometrial Cancer automatically
Every clearance here is in the API, with alerts when new ones post.